Advertisement

Topics

STAT Plus: Pharmalittle: Shkreli investor felt ‘betrayed’; FDA plans SWAT team to speed orphan drug reviews

09:17 EDT 30 Jun 2017 | STAT

An investor in a Martin Shkreli fund spent a year trying to get her investment returned and felt "betrayed" by the delay, even though she made a profit.

Original Article: STAT Plus: Pharmalittle: Shkreli investor felt ‘betrayed’; FDA plans SWAT team to speed orphan drug reviews

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: Shkreli investor felt ‘betrayed’; FDA plans SWAT team to speed orphan drug reviews"

Advertisement
Quick Search
Advertisement
Advertisement